Editorial Series Part 3: Physician: PSE Status Change Would Restrict Access, Raise Costs
1.21.15 – The Tribune Star
If access to pseudoephedrine (PSE) were to be changed from over-the-counter to prescription-only status, this is one Indiana doctor’s diagnosis of what would occur.
• Doctors would see greater patient loads.
• Because of that overload, patients would have to wait longer to get in to see a doctor.
• Patients would find the change inconvenient to their lifestyles and pocketbooks in several ways.
• And the cost of pseudoephedrine, as a prescription drug, would be likely to rise.
Dr. Richard Feldman, director of medical education and family medicine residency at Franciscan St. Francis Health in Indianapolis, strongly holds the view that converting pseudoephedrine to prescription-only would be a mistake.
Read more here.